cc-TDI identifies new drug taken into national clinical trials for childhood cancer
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute